Robert Finizio Net Worth

The estimated Net Worth of Robert G Finizio is at least $47.7 Million dollars as of 10 May 2021. Mr. Finizio owns over 158,334 units of TherapeuticsMD Inc stock worth over $32,107,690 and over the last 13 years he sold TXMD stock worth over $14,346,510. In addition, he makes $1,222,220 as Chief Executive Officer and Director at TherapeuticsMD Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Finizio TXMD stock SEC Form 4 insiders trading

Robert has made over 33 trades of the TherapeuticsMD Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 158,334 units of TXMD stock worth $281,502 on 10 May 2021.

The largest trade he's ever made was selling 982,053 units of TherapeuticsMD Inc stock on 26 March 2014 worth over $6,579,755. On average, Robert trades about 108,040 units every 50 days since 2012. As of 10 May 2021 he still owns at least 18,059,334 units of TherapeuticsMD Inc stock.

You can see the complete history of Mr. Finizio stock trades at the bottom of the page.

Robert Finizio biography

Robert G. Finizio serves as Chief Executive Officer and Director of the Company. As co-founder of VitaMedMD, LLC, or VitaMed, our wholly owned subsidiary, Mr. Finizio served as its Chief Executive Officer and a director from April 2008 to October 2011. Mr. Finizio has 19 years of successful early stage company development experience in the health care industry. Mr. Finizio co-founded and served from August 2001 to February 2008 as President of Care Fusion, LLC and then as Chief Executive Officer of CareFusion, Inc., a clinical technology vendor, which was acquired by Cardinal Health, Inc. Mr. Finizio’s early business experience was with Omnicell, Inc. (formerly known as Omnicell Technologies, Inc.), a provider of pharmaceutical supply chain management systems and services, and Endoscopy Specialists, Inc. in the health care IT and surgical space. Mr. Finizio earned a B.A. from the University of Miami.

What is the salary of Robert Finizio?

As the Chief Executive Officer and Director of TherapeuticsMD Inc, the total compensation of Robert Finizio at TherapeuticsMD Inc is $1,222,220. There are 2 executives at TherapeuticsMD Inc getting paid more, with John Milligan having the highest compensation of $1,440,640.

How old is Robert Finizio?

Robert Finizio is 49, he's been the Chief Executive Officer and Director of TherapeuticsMD Inc since 2012. There are 18 older and 6 younger executives at TherapeuticsMD Inc. The oldest executive at TherapeuticsMD Inc is Tommy Thompson, 78, who is the Independent Chairman of the Board.

What's Robert Finizio's mailing address?

Robert's mailing address filed with the SEC is 951 YAMATO ROAD, SUITE 220, , BOCA RATON, FL, 33431.

Insiders trading at TherapeuticsMD Inc

Over the last 13 years, insiders at TherapeuticsMD Inc have traded over $21,656,853 worth of TherapeuticsMD Inc stock and bought 721,732 units worth $2,299,099 . The most active insiders traders include Cooper C. Collins, Brian Bernick, and Robert G Finizio. On average, TherapeuticsMD Inc executives and independent directors trade stock every 29 days with the average trade being worth of $272,607. The most recent stock trade was executed by John C.K. Iv Milligan on 25 October 2019, trading 72,000 units of TXMD stock currently worth $198,000.

What does TherapeuticsMD Inc do?

therapeuticsmd, inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. we create products to address the unique changes and challenges women experience through every stage of their lives. with momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. this includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitamedmd® and bocagreenmd® brands. see our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines

Complete history of Mr. Finizio stock trades at TherapeuticsMD and TherapeuticsMD Inc

TherapeuticsMD Inc executives and stock owners

TherapeuticsMD Inc executives and other stock owners filed with the SEC include:

• John Milligan,
  President, Secretary
• Brian Bernick,
  Co-Founder
• Robert Finizio,
  Chief Executive Officer and Director
• Robert G. Finizio,
  Co-Founder & Vice Chair
• Mitchell Krassan,
  Chief Strategy and Performance Officer
• John C. K. Milligan IV,
  Chief Exec. Officer of VitaCare Prescription Services
• Michael Donegan,
  Vice President - Finance
• Tommy Thompson,
  Independent Chairman of the Board
• Cooper Collins,
  Independent Director
• J. Martin Carroll,
  Independent Director
• Angus Russell,
  Independent Director
• Jules Musing,
  Independent Director
• Dr. Brian A. Bernick,
  Co-Founder & Chief Scientific Officer
• Nichol Ochsner,
  Vice President, Investor Relations
• Gail Naughton,
  Independent Director
• Karen Ling,
  Independent Director
• Paul Bisaro,
  Independent Director
• Bharat Warrier,
  Chief Manufacturing Officer
• Sebastian Mirkin,
  Chief Medical Officer
• Dawn Halkuff,
  Chief Commercial Officer
• Marlan Walker,
  General Counsel
• John Knighton,
  Chief Compliance Officer
• Adam Miller,
  Chief Information Officer
• James D'Arecca,
  Chief Financial Officer
• Julia M. Amadio,
  Chief Product Officer
• Mitchell L. Krassan,
  Exec. VP and Chief Strategy & Performance Officer
• Chris Gish,
  Sr. VP of Sales
• Michael Donegan,
  Chief Accounting Officer & VP of Fin.
• James C. D'Arecca,
  Chief Financial Officer
• Hugh O'Dowd M.B.A.,
  Pres, CEO & Director
• Robert V Jr La Penta,
  Director
• Nicholas Segal,
  Director
• Jane F Barlow,
  Director
• Daniel A Cartwright,
  Chief Financial Officer
• Randall S Stanicky,
  Director
• Samuel A Greco,
  Director